POSC

Healthcare Medical Devices

Positron Corporation

$1.76

-0.03 -1.51% today

Price History

Not enough data

Key Stats

Market Cap

57.97M

Avg Volume

17,465

EPS

-$0.32

52W High

$2.74

52W Low

$1.27

Div. Yield

0.0%

Valuation

P/B Ratio

-88.25

P/S Ratio

130.33

EV/EBITDA

-5.88

EV/Revenue

131.87

PEG Ratio

73.60

Margins

Gross Margin 0.0%

Operating Margin (718.9%)

Net Margin 0.0%

EBITDA Margin 0.0%

Growth & Returns

Revenue Growth (YoY)

(6.9%)

Liquidity & Leverage

Current Ratio

0.49

Quick Ratio

0.17

Total Cash

357,173

Total Debt

1.04M

About

Positron Corporation, a medical technology company, co-develops, manufactures, and sells positron emission tomography and PET-computed tomography imaging systems in the United States. The company offers Attrius PET and NeuSight PET-CT 64-slice used in non-invasive diagnosis and evaluation of coronary artery disease and supports various molecular imaging applications, including cardiology, oncology, and neurology. It also provides clinical and technical support services, such as physician interpretation training, nurse and technologist training, billing and prior-authorization assistance, physician over-read services, 24/7 clinical and technical support, priority response with after-hours service availability, equipment uptime guarantees and software upgrades, and remote system diagnostics and maintenance capabilities. The company sells its products through internal sales and marketing team. It serves healthcare providers, imaging centers, hospitals, and cardiology practices. The company was incorporated in 1983 and is headquartered in North Tonawanda, New York.